These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34323018)

  • 1. Heart rate modulates the relationship of augmented systolic blood pressure with the blood natriuretic peptide levels.
    Tomiyama H; Nakano H; Takahashi T; Fujii M; Shiina K; Matsumoto C; Chikamori T; Yamashina A
    ESC Heart Fail; 2021 Oct; 8(5):3957-3963. PubMed ID: 34323018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal changes in late systolic cardiac load and serum NT-proBNP levels in healthy middle-aged Japanese men.
    Tomiyama H; Nishikimi T; Matsumoto C; Kimura K; Odaira M; Shiina K; Yamashina A
    Am J Hypertens; 2015 Apr; 28(4):452-8. PubMed ID: 25194157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength of relationships of the pulse wave velocity and central hemodynamic indices with the serum N-terminal fragment B-type natriuretic peptide levels in men: a worksite cohort study.
    Odaira M; Tomiyama H; Matsumoto C; Yoshida M; Shiina K; Nagata M; Yamashina A
    Circ J; 2012; 76(8):1928-33. PubMed ID: 22572462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of arterial stiffness/central hemodynamics with serum cardiac troponin T and natriuretic peptide levels in a middle-aged male worksite cohort.
    Kimura K; Tomiyama H; Matsumoto C; Odaira M; Shiina K; Nagata M; Yamashina A
    J Cardiol; 2015 Aug; 66(2):135-42. PubMed ID: 25467920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.
    Campbell DJ; McGrady M; Prior DL; Coller JM; Boffa U; Shiel L; Liew D; Wolfe R; Stewart S; Reid CM; Krum H
    J Hypertens; 2014 Nov; 32(11):2158-65; discussion 2165. PubMed ID: 25275245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study.
    Satoh M; Hosaka M; Asayama K; Kikuya M; Inoue R; Metoki H; Tsubota-Utsugi M; Hara A; Hirose T; Obara T; Totsune K; Hoshi H; Mano N; Node K; Imai Y; Ohkubo T
    J Hypertens; 2015 Aug; 33(8):1536-41. PubMed ID: 25827428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events.
    Hoshide S; Kanegae H; Kario K
    Hypertens Res; 2021 Sep; 44(9):1138-1146. PubMed ID: 34244693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events　- The Japan Morning Surge-Home Blood Pressure Study.
    Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
    Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of N-Terminal Pro B-Type Natriuretic Peptide With Blood Pressure and Pulse Pressure in Elderly People　- A Cross-Sectional Population Study.
    Sasaki N; Yamamoto H; Ozono R; Fujiwara S; Kihara Y
    Circ J; 2018 Jul; 82(8):2049-2054. PubMed ID: 29794411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
    Welsh P; Doolin O; Willeit P; Packard C; Macfarlane P; Cobbe S; Gudnason V; Di Angelantonio E; Ford I; Sattar N
    Eur Heart J; 2013 Feb; 34(6):443-50. PubMed ID: 22942340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old markers, new approach to assessment of risk in heart failure.
    Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
    Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Welsh P; Poulter NR; Chang CL; Sever PS; Sattar N;
    Hypertension; 2014 Mar; 63(3):507-13. PubMed ID: 24324046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.